QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
15 Maggio 2024 - 10:05PM
Business Wire
Center expands distribution footprint and
reduces waste with greener packaging
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second
state-of-the-art United States distribution center in Pedricktown,
New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
commitment to strengthening supply chain resilience and elevating
the customer experience. In collaboration with a third-party
logistics provider, this investment in redundancy and capacity is
designed to enable QuidelOrtho to fulfill customer orders with
agility.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240515422932/en/
QuidelOrtho opens second U.S.
distribution center (Graphic: Business Wire)
“At QuidelOrtho, we embrace a culture of relentless improvement.
With the startup of our second distribution center in the United
States, we’re making great strides in maintaining and enhancing a
truly robust supply chain approach to distribute our products,”
said Phil McLellan, Senior Vice President, Operations, QuidelOrtho.
“This milestone underscores our dedication to operational
excellence and responsiveness to customer feedback.”
QuidelOrtho values sustainable growth and establishing
eco-friendly supply chains, also moving to greener packaging for
some of its shipments. Its supply chain team has tested a new,
paper-based insulation that is fully “curbside” recyclable. While
the new packaging will not span across every shipment type, it is
expected to positively impact an estimated 15-20% of QuidelOrtho’s
domestic shipments, transitioning over the next several months in
the United States.
“Building upon our responsible resource management, we are proud
of this step toward reducing our environmental footprint,” said Mr.
McLellan. “By embracing innovative solutions and fostering a
culture of continuous improvement, we’re promoting operational
excellence and environmental stewardship.”
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its many years of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is advancing diagnostics to power a healthier
future.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515422932/en/
Investor Contact: Juliet Cunningham Vice President, Investor
Relations IR@QuidelOrtho.com
Media Contact: D. Nikki Wheeler Senior Director, Corporate
Communications media@QuidelOrtho.com
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni QuidelOrtho (NASDAQ:QDEL)
Storico
Da Dic 2023 a Dic 2024